The Patent Finder

Composition and Method for Treating Neurological Disease (2018)

Adamas Pharmaceuticals, Inc.

A patent family: one line of work, grouped by real continuity rather than by a technology label inferred from titles. 3 of these applications claim priority to application 15/898,143, filed Feb 15, 2018. A shared origin can cover several different claimed inventions, which is why members here may not share a title. In-force patents first, soonest term end first, then patent number. Expired patents follow, in the same order.
Confidence:Highevery input resolvedMediumone input unresolvedLowtwo or more caveatsUSPTO recordfrom USPTO's bulk records, without the patent's file history
PatentTitleHolderStatusExpiresPatent lifetimeUsedRemainingConfidence
US 10,213,393Composition and Method for Treating Neurological Disease
In force
 · High confidence
UsedRemaining
Adamas Pharmaceuticals, Inc.In forceHigh confidence
US 10,500,170Composition and Method for Treating Neurological Disease
In force
 · High confidence
Adamas Pharmaceuticals, Inc.In forceHigh confidence
US 10,512,617Composition and Method for Treating Neurological Disease
In force
 · High confidence
Adamas Pharmaceuticals, Inc.In forceHigh confidence
US 11,833,121Composition and Method for Treating Neurological Disease
In force
 · Medium confidence
Adamas Pharmaceuticals, Inc.In forceMedium confidence
Application 16/268,373Composition and Method for Treating Neurological Disease
Abandoned
Abandoned Mar 1, 2021
Adamas Pharmaceuticals, Inc.AbandonedAbandoned Mar 1, 2021
Application 16/670,732Composition and Method for Treating Neurological Disease
Abandoned
Abandoned Apr 9, 2021
Adamas Pharmaceuticals, Inc.AbandonedAbandoned Apr 9, 2021
6 of 6 records shown. In-force patents first, soonest term end first, then patent number. Expired patents follow, in the same order.
4 of these are in force and held by Adamas Pharmaceuticals, Inc..
Updated Nov 21, 2026 · includes USPTO assignment data published Nov 20, 2026, status data published Nov 21, 2026 and grant & fee data published Nov 17, 2026 (weekly) · how we know
Computed patent terms end on the dates shown. Related patents and pending applications may cover overlapping subject matter.
The Patent Finder CompaniesExpirationsCalculatorWatchlistPricing MethodologyCorrectionsLegalPrivacysupport@thepatentfinder.com Updated Nov 21, 2026 · includes USPTO assignment data published Nov 20, 2026, status data published Nov 21, 2026 and grant & fee data published Nov 17, 2026 (weekly) Part of 137 Finder · © 2026 137 Finder LLC · Sources cited